What is Temple?
Temple operates at the intersection of advanced neuroscience and consumer electronics, developing a specialized wearable device designed to monitor physiological signals related to brain circulation. Unlike traditional consumer wearables that focus on peripheral metrics like heart rate or step counts, Temple's technology targets non-invasive, continuous data collection to provide insights into cognitive vitality and long-term brain health. By focusing on the critical nexus of longevity and neurological wellness, the company is carving out a unique niche in the medical device market, aiming to provide users with actionable data that could fundamentally change how individuals manage their cognitive health over time.
How much funding has Temple raised?
Temple has raised a total of $54M across 1 funding round:
Unspecified
$54M
Unspecified (2026): $54M with participation from QED Investors, Dharana Capital, Steadview Capital, Info Edge (India), and Peak XV Partners
Key Investors in Temple
QED Investors
A boutique venture capital firm specializing in early-stage, disruptive financial services and high-growth technology companies across global markets.
Dharana Capital
An investment firm focused on supporting missionary founders in building durable, long-term businesses within the global entrepreneurial ecosystem.
Steadview Capital
A multi-stage investment firm that partners with visionary, founder-led companies, utilizing an integrated framework across public and private markets.
What's next for Temple?
With this major enterprise-level funding, Temple is expected to prioritize the clinical validation of its hardware and the refinement of its data analytics platform. The strategic focus will likely shift toward scaling manufacturing capabilities and navigating the complex regulatory pathways required for medical-grade health monitoring devices. By leveraging the expertise of its high-profile investor base, the company is poised to expand its footprint in the longevity research space, potentially setting a new standard for how physiological data is utilized to predict and maintain cognitive performance in aging populations.
See full Temple company page
